These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 9688265

  • 1. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
    Zákovská A, Nováková O, Balcarová Z, Bierbach U, Farrell N, Brabec V.
    Eur J Biochem; 1998 Jun 15; 254(3):547-57. PubMed ID: 9688265
    [Abstract] [Full Text] [Related]

  • 2. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J, Novakova O, Farrell N, Brabec V.
    Biochemistry; 2003 Jan 28; 42(3):792-800. PubMed ID: 12534292
    [Abstract] [Full Text] [Related]

  • 3. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
    Brabec V, Vrána O, Nováková O, Kleinwächter V, Intini FP, Coluccia M, Natile G.
    Nucleic Acids Res; 1996 Jan 15; 24(2):336-41. PubMed ID: 8628659
    [Abstract] [Full Text] [Related]

  • 4. DNA modifications by antitumor trans-[PtCl2(E-iminoether)2].
    Zaludová R, Zákovská A, Kaspárkova J, Balcarová Z, Vrána O, Coluccia M, Natile G, Brabec V.
    Mol Pharmacol; 1997 Sep 15; 52(3):354-61. PubMed ID: 9281596
    [Abstract] [Full Text] [Related]

  • 5. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
    Brabec V, Christofis P, Slámová M, Kostrhunová H, Nováková O, Najajreh Y, Gibson D, Kaspárková J.
    Biochem Pharmacol; 2007 Jun 15; 73(12):1887-900. PubMed ID: 17400194
    [Abstract] [Full Text] [Related]

  • 6. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
    Kasparkova J, Novakova O, Marini V, Najajreh Y, Gibson D, Perez JM, Brabec V.
    J Biol Chem; 2003 Nov 28; 278(48):47516-25. PubMed ID: 12970368
    [Abstract] [Full Text] [Related]

  • 7. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
    Brabec V, Kaspárková J, Vrána O, Nováková O, Cox JW, Qu Y, Farrell N.
    Biochemistry; 1999 May 25; 38(21):6781-90. PubMed ID: 10346899
    [Abstract] [Full Text] [Related]

  • 8. Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.
    Brabec V, Neplechova K, Kasparkova J, Farrell N.
    J Biol Inorg Chem; 2000 Jun 25; 5(3):364-8. PubMed ID: 10907747
    [Abstract] [Full Text] [Related]

  • 9. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
    Brabec V, Pracharova J, Novakova O, Gibson D, Kasparkova J.
    Dalton Trans; 2015 Feb 28; 44(8):3573-82. PubMed ID: 25406573
    [Abstract] [Full Text] [Related]

  • 10. Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].
    Marini V, Christofis P, Novakova O, Kasparkova J, Farrell N, Brabec V.
    Nucleic Acids Res; 2005 Feb 28; 33(18):5819-28. PubMed ID: 16237123
    [Abstract] [Full Text] [Related]

  • 11. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M, Novakova O, Stepankova J, Novohradsky V, Gibson D, Kasparkova J, Brabec V.
    J Inorg Biochem; 2013 Sep 28; 126():46-54. PubMed ID: 23770803
    [Abstract] [Full Text] [Related]

  • 12. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O, Kasparkova J, Malina J, Natile G, Brabec V.
    Nucleic Acids Res; 2003 Nov 15; 31(22):6450-60. PubMed ID: 14602903
    [Abstract] [Full Text] [Related]

  • 13. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
    Zaludová R, Zákovská A, Kasparková J, Balcarová Z, Kleinwächter V, Vrána O, Farrell N, Brabec V.
    Eur J Biochem; 1997 Jun 01; 246(2):508-17. PubMed ID: 9208945
    [Abstract] [Full Text] [Related]

  • 14. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
    Balcarová Z, Kaspárková J, Zákovská A, Nováková O, Sivo MF, Natile G, Brabec V.
    Mol Pharmacol; 1998 May 01; 53(5):846-55. PubMed ID: 9584210
    [Abstract] [Full Text] [Related]

  • 15. DNA interactions of new antitumor aminophosphine platinum(II) complexes.
    Neplechová K, Kaspárková J, Vrána O, Nováková O, Habtemariam A, Watchman B, Sadler PJ, Brabec V.
    Mol Pharmacol; 1999 Jul 01; 56(1):20-30. PubMed ID: 10385680
    [Abstract] [Full Text] [Related]

  • 16. Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization.
    Khazanov E, Barenholz Y, Gibson D, Najajreh Y.
    J Med Chem; 2002 Nov 21; 45(24):5196-204. PubMed ID: 12431047
    [Abstract] [Full Text] [Related]

  • 17. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V.
    Biochemistry; 2003 May 27; 42(20):6321-32. PubMed ID: 12755637
    [Abstract] [Full Text] [Related]

  • 18. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
    Najajreh Y, Kasparkova J, Marini V, Gibson D, Brabec V.
    J Biol Inorg Chem; 2005 Nov 27; 10(7):722-31. PubMed ID: 16208494
    [Abstract] [Full Text] [Related]

  • 19. Steric control of stereoselective interactions between the platinum(II) complex [PtCl2(1,4-diazacycloheptane)] and DNA: comparison with cis-[PtCl2(NH3)2] and [PtCl2(ethane-1,2-diamine)] using DNA binding and molecular modeling studies.
    Hambley TW, Ling EC, Munk VP, Davies MS.
    J Biol Inorg Chem; 2001 Jun 27; 6(5-6):534-42. PubMed ID: 11472017
    [Abstract] [Full Text] [Related]

  • 20. Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl(2)(Me(2)SO(4))(4)Ru] in cell-free media.
    Nováková O, Hofr C, Brabec V.
    Biochem Pharmacol; 2000 Dec 15; 60(12):1761-71. PubMed ID: 11108791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.